SARS-CoV-2 Spike RBD (L452Q, F490S), His Tag | SPD-C5227

SARS-CoV-2 Spike RBD (L452Q, F490S), His Tag | SPD-C5227 | Acro Biosystems | SARS-CoV-2 Protein Mutants

Synonym

Spike, S protein RBD, Spike glycoprotein Receptor-binding domain, S glycoprotein RBD, Spike protein RBD

Source

SARS-CoV-2 Spike RBD, His Tag (SPD-C5227) is expressed from human 293 cells (HEK293). It contains AA Arg 319 - Lys 537 (Accession # QHD43416.1(L452Q, F490S)). Mutations L452Q, F490S are identified in the SARS-CoV-2 Lambda Variant (C.37).
Predicted N-terminus: Arg 319

Molecular Characterization

Online(Arg 319 - Lys 537) QHD43416.1 (L452Q, F490S)Development Suggestion
This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 26.5 kDa. The protein migrates as 32-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin

Less than 1.0 EU per μg by the LAL method.

Purity

>95% as determined by SDS-PAGE.

>90% as determined by SEC-MALS.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.